Valuation: Becton, Dickinson and Company

Market Cap 5TCr 4.31TCr 4.05TCr 3.69TCr 6.93TCr 4,77700Cr 7.05TCr 48TCr 19TCr 2,39200Cr 19TCr 18TCr 7,94900Cr P/E 2026 *
35.3x
P/E 2027 * 19.7x
Enterprise Value 6.58TCr 5.69TCr 5.34TCr 4.86TCr 9.14TCr 6,29600Cr 9.29TCr 63TCr 24TCr 3,15300Cr 25TCr 24TCr 10,47700Cr EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 day+0.52%
1 week+3.74%
Current month+10.94%
1 month+17.88%
3 months+28.68%
6 months+3.06%
Current year-6.31%
1 week 173
Extreme 173
185.29
1 month 150
Extreme 150
185.29
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
282.76
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+3.74% - - 5TCr
-0.02%+3.19%-15.56%+6.01% 19TCr
+0.76%+4.72%-1.88%+10.18% 12TCr
+1.43%-2.07%+7.17%+69.23% 5.99TCr
+0.32%+3.92%+37.52%+63.82% 5.6TCr
+0.79%+3.70%-6.40%-34.42% 5TCr
-1.89%+5.90%+10.87%-21.62% 3.39TCr
+0.45%+1.45% - - 3.14TCr
+1.98%+12.62%-2.82%+23.87% 2.48TCr
+0.94%-1.31%+41.93%-13.11% 2.46TCr
Average +0.53%+3.69%+8.85%+12.99% 6.55TCr
Weighted average by Cap. +0.43%+3.41%+0.58%+14.12%

Financials

2026 *2027 *
Net sales 1.93TCr 1.67TCr 1.57TCr 1.42TCr 2.68TCr 1,84500Cr 2.72TCr 18TCr 7.17TCr 92TCr 7.24TCr 7.09TCr 3,07000Cr 1.97TCr 1.7TCr 1.6TCr 1.46TCr 2.74TCr 1,88700Cr 2.78TCr 19TCr 7.34TCr 94TCr 7.41TCr 7.25TCr 3,14000Cr
Net income 143.66Cr 124.08Cr 116.6Cr 106.04Cr 199.36Cr 14TCr 202.65Cr 1.37TCr 534.17Cr 6.88TCr 539.38Cr 527.67Cr 23TCr 233.95Cr 202.06Cr 189.88Cr 172.68Cr 324.66Cr 22TCr 330.01Cr 2.22TCr 869.87Cr 11TCr 878.37Cr 859.3Cr 37TCr
Net Debt 1.59TCr 1.37TCr 1.29TCr 1.17TCr 2.2TCr 1,51900Cr 2.24TCr 15TCr 5.91TCr 76TCr 5.96TCr 5.83TCr 2,52800Cr 1.4TCr 1.2TCr 1.13TCr 1.03TCr 1.94TCr 1,33400Cr 1.97TCr 13TCr 5.19TCr 67TCr 5.24TCr 5.12TCr 2,22000Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
14/26/14 $183.28 +0.52% 339
13/26/13 $182.33 +0.57% 468
12/26/12 $181.29 +0.23% 145
11/26/11 $180.88 +1.24% 64
10/26/10 $178.66 +1.13% 164
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
183.40USD
Average target price
194.42USD
Spread / Average Target
+6.01%

Quarterly revenue - Rate of surprise